Is this you? Create Your Porfile
Avatar

Piotr H. Karpinski

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Piotr H. Karpinski is active.

Explore More

Publication

Featured researches published by Piotr H. Karpinski.

Crystal Growth & Design | 2012

Polymorphs, Salts, and Cocrystals: What's in a Name?

Srinivasulu Aitipamula; Rahul Banerjee; Arvind K. Bansal; Kumar Biradha; Miranda L. Cheney; Angshuman Roy Choudhury; Gautam R. Desiraju; Amol G. Dikundwar; Ritesh Dubey; Nagakiran Duggirala; Preetam P. Ghogale; Soumyajit Ghosh; Pramod Kumar Goswami; N. Rajesh Goud; Ram K. R. Jetti; Piotr H. Karpinski; Poonam Kaushik; Dinesh Kumar; Vineet Kumar; Brian Moulton; Arijit Mukherjee; Gargi Mukherjee; Allan S. Myerson; Vibha Puri; Arunachalam Ramanan; T. Rajamannar; C. Malla Reddy; Naír Rodríguez-Hornedo; Robin D. Rogers; T. N. Guru Row

Archive | 2006

Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor

Lili Feng; Sven Erik Godtfredsen; Piotr H. Karpinski; Paul Allen Sutton; Mahavir Prashad; Michael J. Girgis; Bin Hu; Yugang Liu; Thomas J. Blacklock

Tetrahedron Letters | 2012

LCZ696: a dual-acting sodium supramolecular complex

Lili Feng; Piotr H. Karpinski; Paul Allen Sutton; Yugang Liu; David Hook; Bin Hu; Thomas J. Blacklock; Philip E. Fanwick; Mahavir Prashad; Sven Erik Godtfredsen; Christoph Ziltener

Chemical Engineering & Technology | 2006

Polymorphism of Active Pharmaceutical Ingredients

Piotr H. Karpinski

Archive | 2006

Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Paul W. Manley; Wen-Chung Shieh; Paul Allen Sutton; Piotr H. Karpinski; Raeann Wu; Stephanie Monnier; Jörg Brozio

Archive | 2006

Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Paul W. Manley; Wen-Chung Shieh; Paul Allen Sutton; Piotr H. Karpinski; Raeann Wu; Stephanie Monnier; Joerg Brozio

Archive | 2006

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations

Lili Feng; Sven Erik Godtfredsen; Bin Hu; Yugang Liu; Piotr H. Karpinski; Paul Allen Sutton; Mahavir Prashad; Michael J. Girgis; Thomas J. Blacklock

Archive | 2011

Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine

Lili Feng; Baoqing Gong; Piotr H. Karpinski; Liladhar Murlidhar Waykole

Archive | 2007

Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide

Murat Acemoglu; Joginder S. Bajwa; Piotr H. Karpinski; Dimitris Papoutsakis; Joel Slade; Frank Stowasser

Archive | 2010

Polymorphs of a mek inhibitor

Liladhar Murlidhar Waykole; Piotr H. Karpinski; Song Xue; Karen Beltz; Frank Hans Seiler

Explore More

Collaboration

Dive into the Piotr H. Karpinski's collaboration.

Top Co-Authors
Avatar

Paul Allen Sutton

Novartis

View shared research outputs
Top Co-Authors
Avatar

Raeann Wu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Lili Feng

Novartis

View shared research outputs
Top Co-Authors
Avatar

Stephanie Monnier

Novartis

View shared research outputs
Top Co-Authors
Avatar

Paul W. Manley

Novartis

View shared research outputs
Top Co-Authors
Avatar

Wen-Chung Shieh

Novartis

View shared research outputs
Top Co-Authors
Avatar

Liladhar Murlidhar Waykole

Novartis

View shared research outputs
Top Co-Authors
Avatar

Yugang Liu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Bin Hu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Michael J. Girgis

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge